Cargando…

Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model

PURPOSE: Steroid-induced glaucoma is a common form of secondary open angle glaucoma characterized by ocular hypertension (elevated intraocular pressure [IOP]) in response to prolonged glucocorticoid exposure. Elevated IOP occurs with increased outflow resistance and altered trabecular meshwork (TM)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowal, Tia J., Prosseda, Philipp P., Ning, Ke, Wang, Biao, Alvarado, Jorge, Sendayen, Brent E., Jabbehdari, Sayena, Stamer, W. Daniel, Hu, Yang, Sun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107493/ https://www.ncbi.nlm.nih.gov/pubmed/34111256 http://dx.doi.org/10.1167/tvst.10.6.10

Ejemplares similares

Optogenetic stimulation of phosphoinositides reveals a critical role of primary cilia in eye pressure regulation
por: Prosseda, Philipp P., et al.
Publicado: (2020)

Advances in Ophthalmic Optogenetics: Approaches and Applications
por: Prosseda, Philipp P., et al.
Publicado: (2022)

A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion
por: Jabbehdari, Sayena, et al.
Publicado: (2022)

Primary Cilia in Amacrine Cells in Retinal Development
por: Ning, Ke, et al.
Publicado: (2021)

Defective INPP5E distribution in NPHP1‐related Senior–Loken syndrome
por: Ning, Ke, et al.
Publicado: (2020)

Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks, Cassandra C, et al.
Publicado: (2020)

Erroneous assumption of ocular hypertension in patients with elevated intraocular pressure
por: Rewri, Parveen, et al.
Publicado: (2022)

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
por: Jayanetti, Viran, et al.
Publicado: (2020)

Change of Retinal Vessel Density After Lowering Intraocular Pressure in Ocular Hypertension
por: Chen, Xuhao, et al.
Publicado: (2021)

Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice
por: Patel, Gaurang C., et al.
Publicado: (2018)

Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
por: Patel, Gaurang C., et al.
Publicado: (2019)

Effect of interscalene block on intraocular pressure and ocular perfusion pressure
por: Basaran, Betul, et al.
Publicado: (2017)

Adrenal and Glucocorticoid Effects on the Circadian Rhythm of Murine Intraocular Pressure
por: Tsuchiya, Shunsuke, et al.
Publicado: (2018)

Twenty-four-hour repeatability of diurnal intraocular pressure patterns in glaucomatous and ocular hypertensive individuals
por: Hatanaka, Marcelo, et al.
Publicado: (2011)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Pozarowska, Dorota
Publicado: (2010)

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
por: Lee, Anne J, et al.
Publicado: (2010)

The effect of phacoemulsification surgery on intraocular pressure and anterior segment anatomy of the patients with cataract and ocular hypertension
por: Cetinkaya, Servet, et al.
Publicado: (2015)

Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension
por: Jóhannesson, Gauti, et al.
Publicado: (2020)

Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models
por: Roy Chowdhury, Uttio, et al.
Publicado: (2022)

Intraocular pressure and ocular biometric parameters changes in migraine
por: Koban, Yaran, et al.
Publicado: (2016)

Endogenous ocular lipids as potential modulators of intraocular pressure
por: Edwards, Genea, et al.
Publicado: (2020)

Commentary: Exercise, intraocular pressure, and ocular blood flow
por: Sathi Devi, A V
Publicado: (2022)

Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure–Lowering Effects of Latanoprost
por: Roddy, Gavin W., et al.
Publicado: (2017)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Aihara, Makoto
Publicado: (2010)

Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
por: Bozic, Marija M, et al.
Publicado: (2016)

Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension
por: Fang, Yuan, et al.
Publicado: (2017)

Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
por: Yasuda, Mami, et al.
Publicado: (2017)

Corneal biomechanics and biomechanically corrected intraocular pressure in primary open-angle glaucoma, ocular hypertension and controls
por: Vinciguerra, Riccardo, et al.
Publicado: (2020)

Sealed Unilateral Full-Thickness Macular Hole with Amniotic Membrane Graft in a Patient with Alport Syndrome: A Case Report
por: Jabbehdari, Sayena, et al.
Publicado: (2023)

Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish
por: De Marco, Rodrigo J., et al.
Publicado: (2013)

Physiology-Enhanced Data Analytics to Evaluate the Effect of Altitude on Intraocular Pressure and Ocular Hemodynamics
por: Vercellin, Alice Verticchio, et al.
Publicado: (2022)

Review of Ocular Manifestations of Joubert Syndrome
por: Wang, Stephanie F., et al.
Publicado: (2018)

Increased Intraocular Pressure During Hemodialysis: Ocular Dialysis Disequilibrium
por: Maja, Ayodele K., et al.
Publicado: (2022)

Intereye Differences in the Clinical Assessment of Intraocular Pressure and Ocular Biomechanics
por: Yuhas, Phillip T., et al.
Publicado: (2023)

The Intraocular Pressure Lowering Effect of a Dual Kinase Inhibitor (ITRI-E-(S)4046) in Ocular Hypertensive Animal Models
por: Chen, Yi-Hsun, et al.
Publicado: (2021)

Longitudinal stability of the diurnal rhythm of intraocular pressure in subjects with healthy eyes, ocular hypertension and pigment dispersion syndrome
por: Huchzermeyer, Cord, et al.
Publicado: (2014)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective
por: Raj, Pallavi, et al.
Publicado: (2021)

Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
por: Sharif, Najam A.
Publicado: (2023)

Ophthalmologic Findings in Patients with Neuro-metabolic Disorders
por: Jafari, Narjes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1khe3dc45t2oh3n0eg9gmr6q0g